Kindred Biosciences, Inc.
KIN
KIN was delisted on the 27th of August, 2021.
44 hedge funds and large institutions have $42.4M invested in Kindred Biosciences, Inc. in 2016 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 13 increasing their positions, 14 reducing their positions, and 9 closing their positions.
9% more capital invested
Capital invested by funds: $38.9M → $42.4M (+$3.55M)
7% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 14
12% less funds holding
Funds holding: 50 → 44 (-6)
67% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
Ariel Investments
Chicago,
Illinois
|
+$3.85M |
| 2 |
JP Morgan Chase
New York
|
+$735K |
| 3 |
RA
Royce & Associates
New York
|
+$205K |
| 4 |
Prudential Financial
Newark,
New Jersey
|
+$197K |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$162K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$526K |
| 2 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$508K |
| 3 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$311K |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$170K |
| 5 |
Renaissance Technologies
New York
|
-$170K |
KIN Hedge Fund Activity: Q1 2016 in Review
44 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Kindred Biosciences, Inc. (KIN) for Q1 2016, worth a combined $42.4M — up 9.1% from $38.9M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of KIN and 3 opened new positions — a net loss of 6 holders — while 14 trimmed existing stakes and 13 added.
The largest buyer was Ariel Investments, adding an estimated $3.85M. The largest seller was Wells Fargo, cutting an estimated $526K.
- 44 institutional investors held Kindred Biosciences, Inc. (KIN) as of Q1 2016, down from 50 in Q4 2015.
- Funds reported $42.4M of Kindred Biosciences, Inc. stock for Q1 2016, up 9.1% quarter-over-quarter.
- 3 funds opened new Kindred Biosciences, Inc. positions in Q1 2016 and 9 closed out, a net change of -6 holders.
- The largest Kindred Biosciences, Inc. buyer in Q1 2016 was Ariel Investments, an estimated $3.85M added.
- The largest Kindred Biosciences, Inc. seller in Q1 2016 was Wells Fargo, an estimated $526K sold.
Based on aggregated 13F filings for Q1 2016.